Results for “ ”

Entry Author Date Location
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech 05/27/20 Boston
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
Bio Roundup: FDA Dings BMS, Genfit’s Fall, Alexion’s Activist & More 05/15/20 National
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
Encouraging Signals for New Cancer Cell Therapy Strategies 05/06/20 National
Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More 05/01/20 National
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More 04/24/20 National
Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19) 04/22/20 National
New COVID-19 Special Reports Explore Clinical Research During the Pandemic 04/21/20 Boston
Bio Roundup: Alnylam’s Billions, COVID-19 Vaccines, Moma Debuts & More 04/17/20 National
GSK and Sanofi Team Up on COVID-19 Vaccine, Aim for Clinic This Year 04/14/20 National
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Pfizer, BioNTech Say mRNA COVID-19 Vaccine Trials May Start This Month 04/09/20 National
Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment 04/06/20 Boston
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
Oncology Needs Combo Therapies & More Data Analysis, Says Bio-Europe Spring Panel 03/26/20 Boston
Investors Shaken by Coronavirus Sow Seeds of M&A, Financing Slowdown 03/23/20 National
Bio Roundup: Coronavirus Diagnostics, Therapeutics, Vaccines & More 03/20/20 National
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future 03/19/20 Boston
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More 03/13/20 National
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More 03/06/20 National
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
Lundbeck’s Alder Bio Bet Pays Off With FDA Approval of Migraine Drug 02/23/20 National
Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce’s $88M & More 02/21/20 National
Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More 02/14/20 National
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks 02/13/20 National
Two Big Pharma Alliances End in Nixed Deals. Here’s What Happened. 02/11/20 National
Page 2 of 78 « previous page · next page »